Garvey Christine, Ortiz Gabriel
Seton Pulmonary and Cardiac Rehabilitation, Daly City, CA, USA.
Open Nurs J. 2012;6:13-9. doi: 10.2174/1874434601206010013. Epub 2012 Feb 10.
Epidemiologic data indicate that chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality. Patients with poorly managed COPD are likely to experience exacerbations that require emergency department visits or hospitalization-two important drivers contributing to escalating healthcare resource use and costs associated with the disease. Exacerbations also contribute to worsening lung function and negative outcomes in COPD. The aim of this review is to present the perspective of nurse practitioners and physician assistants in terms of providing the pharmacologic and non-pharmacologic modalities needed to treat current and prevent future exacerbations. Major respiratory guidelines recommend treatment of acute exacerbations with short-acting bronchodilators, oral corticosteroids and antibiotics, as appropriate. Supplementary oxygen and/or ventilatory support may also be beneficial to selected patients. Treatments to minimize the risk of future exacerbations should include maintenance pharmacotherapies, risk-reduction measures (e.g. smoking cessation, influenza and pneumonia vaccinations), pulmonary rehabilitation, self-management support and follow-up care.
流行病学数据表明,慢性阻塞性肺疾病(COPD)是发病和死亡的主要原因。COPD管理不善的患者很可能会经历急性加重,这需要前往急诊科就诊或住院治疗,这是导致医疗资源使用增加和该疾病相关费用上升的两个重要因素。急性加重还会导致COPD患者的肺功能恶化和不良后果。本综述的目的是从执业护士和医师助理的角度,介绍治疗当前急性加重和预防未来急性加重所需的药物和非药物治疗方法。主要的呼吸指南建议,酌情使用短效支气管扩张剂、口服糖皮质激素和抗生素治疗急性加重。补充氧气和/或通气支持对部分患者可能也有益处。将未来急性加重风险降至最低的治疗方法应包括维持药物治疗、降低风险措施(如戒烟、流感和肺炎疫苗接种)、肺康复、自我管理支持和随访护理。